A Mendelian analysis supports the idea that hyperuricemia may be an important risk factor for pulmonary arterial hypertension ...
Medpage Today on MSN5d
Have the New Pulmonary Hypertension Drugs Changed the Game?In March, we reported on back-to-back FDA approvals for two treatments in pulmonary arterial hypertension (PAH). In this ...
4don MSN
On an overcast Tuesday in December, Michael Hale stood before a group of students at the Portland Opportunities Industrial ...
As prevalence of CVDs continues to increase, the AHA and AMA have developed the Target BP initiative to improve blood ...
Chinese scientists have found a common hypertension drug could prove potent in treating a rare but highly invasive brain ...
Steve Van Wormer has published nearly 500 podcasts about pulmonary hypertension (PH) — more than perhaps anyone working in rare diseases.
PAH, or pulmonary hypertension, can leave someone breathless even after a short walk, but better drug combinations have ...
People with high blood pressure who slept for shorter durations were more likely to show poor cognitive function and ...
Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s (NYSE:MRK) Winrevair ...
The differences did not appear to be associated with potential moderating factors like age, sex, or smoking status.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback